World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02090244
Date of registration: 16/03/2014
Prospective Registration: No
Primary sponsor: University Hospital, Linkoeping
Public title: Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?
Scientific title: Förbättrar PTH Postero-lateral fusionsläkning Vid Ryggkirurgi?
Date of first enrolment: August 2012
Target sample size: 34
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02090244
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).  
Phase:  Phase 4
Countries of recruitment
Sweden
Contacts
Name:     Jon Ottesen, MD
Address: 
Telephone:
Email:
Affiliation:  Ryggkliniken, US Linköping
Name:     Patrik Bernestrå, MD
Address: 
Telephone:
Email:
Affiliation:  Ortopedkliniken, Kalmar, Sweden
Key inclusion & exclusion criteria

Inclusion Criteria:

- lumbar spinal stenosis operated on with decompression and bone grafting. All ages are
accepted, but women must be postmenopausal.

Exclusion Criteria:

- •dementia or psychiatric disorder

- known malignancy < 5 years prior to fracture

- calcium above reference value

- signs of liver disease

- creatinine over ref. value

- inflammatory joint disease

- alcohol or drug abuse

- oral corticosteroid medication

- long-term NSAID-treatment (=> 3 months prior to fracture)



Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Spinal Stenosis
Intervention(s)
Drug: Teriparatide
Primary Outcome(s)
The rate of bone healing after spinal stenosis surgery [Time Frame: 6 months + more than 2 years postoperatively.]
Secondary Outcome(s)
Pain [Time Frame: At 3 and 6 months.]
Function [Time Frame: At 3 and 6 months.]
Secondary ID(s)
2011-002917-12
PTH spinal stenosis
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Medical Research Council of Southeast Sweden
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history